Dan Tarjan

Dan Tarjan is a Senior Associate at Corbets Capital, specializing in long/short healthcare strategies since November 2023. Prior experience includes serving as Vice President of Equity Research at Leerink Partners, focusing on diversified biopharma from November 2020 to November 2023. Dan Tarjan worked as an Equity Research Associate at nference, where contributions enhanced client decision-making in biopharma between July 2018 and November 2020. Dan Tarjan's academic background includes a PhD from Harvard Medical School, where the thesis was featured in Nature Communications Editors’ Highlights and supported by a $40K Broad Institute grant. Additional experience includes research and internships at Flagship Pioneering, the British Consulate-General in Boston, and Lawrence Berkeley National Laboratory. Higher education includes a BS in Biology and Computer Science from the University of Virginia.